Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ARK Genomic Revolution ETF (ARKG) vs State Street SPDR Bloomberg High Yield Bond ETF (JNK) Price & Performance

ARK Genomic Revolution ETF
State Street SPDR Bloomberg High Yield Bond ETF

Price performance

Price movement over the last 24 hours

Key statistics

ARK Genomic Revolution ETF vs State Street SPDR Bloomberg High Yield Bond ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while State Street SPDR Bloomberg High Yield Bond ETF trades at $95.93. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, State Street SPDR Bloomberg High Yield Bond ETF nearer its low. Which is the better fit depends on your goals.

ARKGJNK
Sector
Sector/ThematicFixed Income
52-Week High
$43.57$98.19
52-Week Low
$23.09$94.66

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ARK Genomic Revolution ETF

ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.

The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.

State Street SPDR Bloomberg High Yield Bond ETF

JNK trades at $95.93, down 0.07% on the day, with a bearish technical signal from moving averages and oscillators showing neutral readings. The ETF has declared dividends for 2026, including $0.53 for H2-26. Recent news highlights strong bond ETF inflows amid inflation fears and potential Fed rate hikes, creating a volatile backdrop for high-yield bonds.

Outlook remains cautious due to bearish technicals and macroeconomic uncertainty. Opportunities exist for yield-seeking investors, but risks include interest rate sensitivity and fund fees. Investors should weigh the ETF's high-yield exposure against potential headwinds from rising rates and economic shifts.

Returns comparison

Trailing returns across standard periods

About ARK Genomic Revolution ETF

ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.

Read more on ARKG

About State Street SPDR Bloomberg High Yield Bond ETF

JNK is a major ETF tracking the Bloomberg High Yield Very Liquid Index. It provides exposure to U.S. dollar-denominated junk bonds with above-average liquidity, featuring 2026 top holdings like EchoStar, Cloud Software Group, and Carnival Corp.

Read more on JNK